The Vevo LAZR is a crucial breakthrough with wide ranging implications for cancer research," said Dr.
The Vevo LAZR photoacoustics system is a breakthrough in vivo imaging technology," said Anil Amlani, VisualSonics' President and CEO.
The launch of the Vevo LAZR technology further demonstrates our commitment in providing game changing imaging technology to advance pre-clinical research," said Kevin M.
The Vevo LAZR system supports VisualSonics' continuous efforts to provide researchers with innovative solutions to improving pre-clinical research.
Researchers are invited to experience a demonstration of the Vevo LAZR system by visiting VisualSonics at booth #2171 at AACR.
Nasdaq:Sono), today announced the launch of the Vevo[R] LAZR Photoacoustics Imaging system for the advancement of cancer research in the pre-clinical imaging market.
After two years of research and development, images and data generated by the Vevo LAZR system were presented at the World Molecular Imaging Conference (WMIC) in Kyoto, Japan in September 2010, where the system received strong feedback from prestigious organizations and research institutes from around the globe.
The Vevo LAZR photoacoustics system is the future of pre-clinical research," said Anil Amlani, VisualSonics' President and CEO.
The platform of the Vevo LAZR system integrates proprietary imaging capabilities that will further improve a researcher's overall experience and will set new standards for performance in pre-clinical research.
Amlani continued, "We believe the Vevo LAZR system will have a strong impact on the discovery of new cancer therapies in the pre-clinical market space and that we will see a translation of these discoveries into practical applications in humans.